# CD4CAR for CD4+ Leukemia and Lymphoma

> **NCT03829540** · PHASE1 · RECRUITING · sponsor: **Huda Salman** · enrollment: 20 (estimated)

## Conditions studied

- T-cell Lymphoma
- T-cell Leukemia

## Interventions

- **BIOLOGICAL:** CD4CAR

## Key facts

- **NCT ID:** NCT03829540
- **Lead sponsor:** Huda Salman
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-09
- **Primary completion:** 2026-12
- **Final completion:** 2041-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03829540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03829540, "CD4CAR for CD4+ Leukemia and Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03829540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*